Research ExplorerScientific StaffKristoffer Riecken Publications

Priv.-Doz. Dr. rer. nat. ID: 53973

Kristoffer Riecken

graph of relations
Affiliations
Links
ORCID: 0000-0001-9050-6766
101 - 114 out of 114Page size: 50

Publications

  1. 2012

  2. RGB marking with lentiviral vectors for multicolor clonal cell tracking.

    Riecken, K., Thomaschewski, M., Benten, D. & Fehse, B., 2012, In: NAT PHYS. 7, 5, p. 839-849 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. SOCS3 promotes interleukin-17 expression of human T cells.

    Kleinsteuber, K., Heesch, K., Schattling, S., Sander-Juelch, C., Mock, U., Riecken, K., Fehse, B., Fleischer, B. & Jacobsen, M., 2012, In: BLOOD. 120, 22, p. 4374-4382 22.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2011

  5. Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

    Michaelis, M., Rothweiler, F., Barth, S., Cinatl, J., van Rikxoort, M., Löschmann, N., Voges, Y., Breitling, R., von Deimling, A., Rödel, F., Riecken, K., Fehse, B., Mack, E., Stiewe, T., Doerr, H. W., Speidel, D., Cinatl, J. & Riecken, K., 01.01.2011, In: CELL DEATH DIS. 2, p. e243

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.

    Preuß, E., Muik, A., Riecken, K., Otte, J., von Laer, D. & Fehse, B., 2011, In: J MOL MED. 89, 11, p. 1113-1124 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. RGB marking facilitates multicolor clonal cell tracking.

    Riecken, K., Thomaschewski, M., Warlich, M., Volz, T., Cornils, K., Niebuhr, B., Täger, M., Lütgehetmann, M., Pollok, J-M., Stocking, C., Dandri-Petersen, M., Benten, D. & Fehse, B., 2011, In: NAT MED. 17, 4, p. 504-509 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2010

  9. Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells.

    Rothweiler, F., Michaelis, M., Brauer, P., Otte, J., Riecken, K., Fehse, B., Doerr, H. W., Wiese, M., Kreuter, J., Al-Abed, Y., Nicoletti, F. & Cinatl, J., 2010, In: NEOPLASIA. 12, 12, p. 1023-1030 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Highly efficient lentiviral transduction of phenotypically and genotypically characterized endothelial progenitor cells from adult peripheral blood.

    Stockschlaeder, M., Shardakova, O., Riecken, K., Stoldt, V. R., Fehse, B., Giers, G. & Scharf, R. E., 2010, In: BLOOD COAGUL FIBRIN. 21, 5, p. 464-473 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.

    Vafaizadeh, V., Klemmt, P., Brendel, C., Riecken, K., Doebele, C., Britt, K., Grez, M., Fehse, B., Desriviéres, S. & Groner, B., 2010, In: STEM CELLS. 28, 5, p. 928-938 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.

    Preuß, E., Treschow, A., Newrzela, S., Brücher, D., Riecken, K., Felldin, U., Alici, E., Gahrton, G., von Laer, D., Dilber, M. S. & Fehse, B., 2010, In: HUM GENE THER. 21, 8, p. 929-941 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2009

  14. Diva-Fit: A step-by-step manual for generating high-resolution graphs and histogram overlays of flow cytometry data obtained with FACSDiva software

    Riecken, K. & Fehse, B., 2009, In: CTT-Cell Ther Transpl. 1, 4, p. 1-4 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis.

    Riecken, K., Mock, U., Petrowitz, B., Bartsch, U. & Fehse, B., 2009, In: GENE THER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3.

    Michaelis, M., Rothweiler, F., Klassert, D., von Deimling, A., Riecken, K., Fehse, B., Kammerer, B., Doerr, H. W. & Cinatl, J., 2009, In: CANCER RES. 69, 2, p. 416-421 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2008

  18. A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis

    Weber, K., Bartsch, U., Stocking, C. & Fehse, B., 2008, In: MOL THER. 16, 4, p. 698-706 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate.

    Schüler, A., Schwieger, M., Engelmann, A., Riecken, K., Horn, S., Müller, U., Arnold, M. A., Olson, E. N. & Stocking, C., 2008, In: BLOOD. 111, 9, p. 4532-4541 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next